Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Faricimab Schedules for Age-Related Macular Degeneration
Recruiting2 awardsPhase 3
St. Louis, Missouri
This trial compares two different approaches for treating age-related macular degeneration using a type of imaging called optical coherence tomography.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service